Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows a new revision number in the footer (v3.5.4) compared with the previous version. The overall study details and content on the page remain the same.
    Difference
    0.1%
    Check dated 2026-05-15T05:48:48.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page footer revision number was updated from v3.5.2 to v3.5.3, indicating a non-content site/version change.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:56.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:21:02.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.5.0. The previous revision v3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-18T21:03:58.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3; the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T20:18:41.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    The update adds Revision: v3.4.2 and removes the earlier government-funding notice (v3.4.1), a minor maintenance update to the page.
    Difference
    0.5%
    Check dated 2026-02-11T09:25:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.